In this weeks’ video, Dr. Durie discusses what effect a new treatment can have on your myeloma protein levels, and when it can be time to consider changing your treatment regimen with your doctor.
The BOTTOM line:
Venetoclax will move forward as a “targeted” precision medicine approach for patients with the t(11;14) abnormality.
Please subscribe to our channel!
Subscribe to International Myeloma Foundation: bit.ly/XlUtPE
Visit our website at: www.myeloma.org
Find us online:
Facebook: / myeloma
Google+: gplus.to/imfmye...
IMF on twitter: @IMFMyeloma ( / imfmyeloma )
Dr. Durie on twitter: @BrianDurieMD ( / brianduriemd )
Support the IMF! bit.ly/WskQHC
Category
Nonprofits & Activism
License
Standard KZfaq License